Sounds very exiting to me. Mark and Co are now confident enough to take the partnering program to the next step. As I mentioned before it's about bargaining power, and they would not engage Destum before they had what they needed.
From the destum site:
'We have successfully completed fourteen (14) transactions since 2010 to include deals with major pharmaceutical companies such as Boehringer Ingelheim, Eli Lilly, Johnson & Johnson, Novartis, Pfizer, and Sanofi.'
Destum has the contacts, it's all business and legal from here.
ANP Price at posting:
14.0¢ Sentiment: Buy Disclosure: Held
